Angina Pectoris

• FDA approval · 2007-07-11
  FDA Approved: AMLODIPINE BESYLATE — Original Application (ACI Healthcare USA, Inc.)

  FDA approved the original application for amlodipine besylate from ACI Healthcare USA, Inc., approving a generic version of this antihyperte…

• FDA approval · 2007-07-09
  FDA Approved: AMLODIPINE BESYLATE — Original Application (Zydus Pharmaceuticals USA Inc.)

  FDA approved the original application for amlodipine besylate from Zydus Pharmaceuticals USA Inc., a generic version of amlodipine used to t…

• FDA approval · 2007-06-21
  FDA Approved: PROPRANOLOL HYDROCHLORIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for propranolol hydrochloride (generic) from Hikma Pharmaceuticals USA Inc., indicating an approval …

• CLINICAL_TRIALS trial_result · 2007-05-30
  Clinical Trial Update: Blood Pressure Interaction Between Sildenafil and Sublingual Glyceryl Trinitrate (GTN) in Men With Angina [Phase 4]

  A Phase 4 clinical trial evaluated the blood pressure interaction between sildenafil and sublingual glyceryl trinitrate (GTN) in men with an…

• FDA approval · 2007-05-30
  FDA Approved: METOPROLOL TARTRATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved Hikma Pharmaceuticals USA Inc.'s original ANDA for metoprolol tartrate, a generic beta-blocker used to treat cardiovascular…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2007-05-23
  FDA Approved: AMLODIPINE BESYLATE — Original Application (PD-Rx Pharmaceuticals, Inc.)

  FDA approved a new original-application generic amlodipine besylate tablet from PD-Rx Pharmaceuticals, Inc. Indications include hypertension…

• FDA approval · 2007-04-19
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for verapamil hydrochloride from Actavis Pharma, Inc., granting approval of a supplemental indicatio…

• FDA approval · 2007-04-12
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  The FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., confirming regulatory approval of an upda…

• FDA approval · 2007-04-12
  FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for Verapamil Hydrochloride from Actavis Pharma, Inc., updating the approval status for this generic…

• CLINICAL_TRIALS trial_result · 2007-04-11
  Clinical Trial Update: Does Telephone Follow-up Improve Patients Satisfaction

  A completed clinical trial update evaluating whether telephone follow-up improves patient satisfaction among patients with congestive heart …

• FDA label_change · 2007-03-14
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  FDA approved a supplemental application for TOPROL XL (metoprolol succinate) submitted by Melinta Therapeutics, LLC.

• FDA approval · 2007-03-01
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  The FDA approved a supplemental application for Atenolol from Zydus Lifesciences Limited under an ANDA. The action approves changes to the g…

• FDA label_change · 2007-02-21
  FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

  FDA approves a supplemental application for Inderal LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc., resulting in labe…

• FDA approval · 2007-01-27
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  FDA approved a supplemental application for Atenolol submitted by Zydus Lifesciences Limited.

• FDA approval · 2007-01-03
  FDA Approved: INDERAL LA — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for INDERAL LA (propranolol hydrochloride) submitted by ANI Pharmaceuticals, Inc. This action au…

• FDA approval · 2006-12-27
  FDA Approved: ATENOLOL — Original Application (Ipca Laboratories Limited)

  FDA approved the original ANDA for Atenolol by Ipca Laboratories Limited, authorizing a generic atenolol product. Atenolol is used for condi…

• FDA approval · 2006-12-04
  FDA Approved: CARTIA XT — Supplemental Application (Actavis Pharma, Inc.)

  FDA approved a supplemental application for CARTIA XT (diltiazem hydrochloride) submitted by Actavis Pharma, Inc., authorizing changes to th…

• FDA approval · 2006-09-28
  FDA Approved: NITROGLYCERIN — Supplemental Application (Prasco Laboratories)

  FDA approved a supplemental application for nitroglycerin submitted by Prasco Laboratories.

• FDA approval · 2006-09-13
  FDA Approved: ATENOLOL — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved Atenolol as a generic under ANDA077443 from Rising Pharma Holdings, Inc. for the treatment of hypertension, angina pectoris, an…

• CLINICAL_TRIALS withdrawal · 2006-09-08
  Clinical Trial Update: Study Protocol for Rosiglitazone Versus Gliclazide in Diabetics With Angina [Phase 4]

  A Phase 4 trial comparing rosiglitazone versus gliclazide in adults with type 2 diabetes and angina has been withdrawn.

• FDA approval · 2006-07-27
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) from Melinta Therapeutics, LLC. The approval updates the pr…

• FDA approval · 2006-07-17
  FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)

  The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).

• FDA approval · 2006-05-04
  FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)

  FDA approved a supplemental application for TOPROL XL (metoprolol succinate) sponsored by Melinta Therapeutics, LLC.